These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 6373140

  • 1. Allogeneic bone marrow transplantation.
    Weiden PL.
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC, McGuire TR.
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 4. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T, Masaoka T, Shibata H.
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation in Canada.
    Buskard NA.
    Can Med Assoc J; 1980 Jul 05; 123(1):19-22. PubMed ID: 6998551
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation in children: Tokai experience 1982 to 1984.
    Kato S, Hoshi N, Nagasaka M, Muranaka S, Yabe H, Kimura M.
    Tokai J Exp Clin Med; 1985 Jun 05; 10(2-3):147-58. PubMed ID: 3010509
    [Abstract] [Full Text] [Related]

  • 7. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, Jeannet M.
    Schweiz Med Wochenschr; 1983 Apr 30; 113(17):622-9. PubMed ID: 6346483
    [Abstract] [Full Text] [Related]

  • 8. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ.
    Clin Cancer Res; 1997 Dec 30; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow transplantation in severe aplastic anemia and acute or chronic leukemia.
    Schaefer UW, Mahmoud HK, Beelen DW, Hoffmann W, Becher R, Schmidt CG, Bamberg M, Quast U, Haralambie E, Linzenmeier G.
    Strahlenther Onkol; 1986 Apr 30; 162(4):214-7. PubMed ID: 3518096
    [Abstract] [Full Text] [Related]

  • 10. [Progress in bone marrow transplantation in acute leukemia and aplastic anemia].
    Speck B, Cornu P, Sartorius J, Nissen C, Gratwohl A, Burri HP, Jeannet M.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1883-5. PubMed ID: 43594
    [Abstract] [Full Text] [Related]

  • 11. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec 08; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

  • 12. [Indications and results in bone marrow transplantation].
    Jeannet M, Chapuis B.
    Ther Umsch; 1986 Feb 08; 43(2):138-43. PubMed ID: 3515608
    [No Abstract] [Full Text] [Related]

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 08; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic bone marrow transplantation for the patients with hemopoietic stem cell disorders: CUMC experience.
    Kim DJ, Kim CC, Park CW, Han CH, Kim HK, Kim WI, Han KJ, Choi IB.
    Gan To Kagaku Ryoho; 1992 Jul 08; 19(8 Suppl):1188-92. PubMed ID: 1514832
    [Abstract] [Full Text] [Related]

  • 15. Overview of marrow transplantation.
    Thomas ED.
    West J Med; 1985 Dec 08; 143(6):834-7. PubMed ID: 3911595
    [Abstract] [Full Text] [Related]

  • 16. Graft-versus-host disease after marrow transplantation.
    Storb R.
    Prog Clin Biol Res; 1986 Dec 08; 224():139-57. PubMed ID: 3540990
    [Abstract] [Full Text] [Related]

  • 17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 08; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 18. Marrow transplantation: the Seattle experience.
    Storb R.
    Tokai J Exp Clin Med; 1985 Jun 08; 10(2-3):75-83. PubMed ID: 3914747
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
    Ringdén O, Aschan J, Boström L, Dahllöf G, Tollemar J, Paulin T, Gahrton G, Groth CG, Klaesson S, Lindquist R.
    Clin Transpl; 1990 Jun 08; ():175-87. PubMed ID: 2103143
    [Abstract] [Full Text] [Related]

  • 20. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 08; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.